Company: SHPH
Filing Date: 2025-05-06
Form Type: DEF 14A
Source: 0001641172-25-008884
Chunk: 2

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-05-06
Form: DEF 14A
Chunk 2
---
 than the “Minimum Price” as defined in Nasdaq Listing Rule 5635(d). We are seeking approval for two proposal that will result in sales of common stock in excess of 20%: (1) the sale of preferred stock that will convert into common stock at a floating 10% discount to market and (2) sale of our common stock pursuant to an equity line of credit (“ELOC”), which stock will be sold at a 10% discount to market. Thus, in order to comply with Nasdaq listing rules, assuming we have a quorum of stockholders at our Annual Meeting, we will need the approval of a plurality of stockholders voting at our Annual Meeting in order to obtain approval on each of these matters in order to allow for the issuance of 20% or more of our common stock (or preferred stock convertible into common stock) at a price below the “Minimum Price” as defined in Nasdaq Listing Rule 5635(d).

The Company is hereby seeking stockholder approval to the following additional item of business:

| ITEMS                                                                                                                            
 OF BUSINESS                                                                                                                      |     | BOARD                 
 VOTING RECOMMENDATION |
| Proposal                                                                                                                         
 No. 7: To approve, in compliance with Nasdaq Listing Rule 5635(d), the sale and issuance of more than 20% of the Company’s       
 issued and outstanding common stock (or preferred stock convertible into common stock) at a price lower than the “Minimum Price” 
 as defined in Nasdaq Listing Rule 5635(d).                                                                                       |     | FOR                   |
| Proposal                                                                                                                         
 No. 8: To approve, in compliance with Nasdaq Listing Rule 5635(d), the sale and issuance of more than 20% of the Company’s       
 issued and outstanding common stock pursuant to a planned equity line of credit agreement a price lower than the “Minimum Price” 
 as defined in Nasdaq Listing Rule 5635(d)                                                                                        |     | FOR                   |

| PROXY                                  
 VOTING                                 |     |                                                                            |     |                                         |     |                                                          |
| Internet                               |     | Meeting                                                                    |     | Phone                                   |     | Mail                                                     |
| Visit                                  
 the web site listed on your proxy card |     | Vote                                                                       
 at the Annual Meeting online at www.virtualshareholdermeeting.com/SHPH2025 |     | Call                                    
 the telephone number on your proxy card |     | Sign,                                                    
 date and return your proxy card in the enclosed envelope |

PROPOSAL NO